Get Premium to unlock powerful stock data
Cerus Corp logo

Cerus Corp

$ 4.84 +0.01 (+0.21%) 04:00 PM EST
P/E:
At Loss
P/B:
10.81
Market Cap:
$ 856.19M
Enterprise V:
$ 834.40M
Volume:
1.79M
Avg Vol (2M):
2.18M
Also Trade In:
Volume:
1.79M
Market Cap $:
856.19M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.18M
Enterprise Value $:
834.40M
PB Ratio:
10.81
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Cerus Corp
NAICS : 339112 SIC : 3845
1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520
Description
Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Name Current Vs Industry Vs History
Cash-To-Debt 1.23
Equity-to-Asset 0.36
Debt-to-Equity 1.12
Debt-to-EBITDA -2.19
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.83
Distress
Grey
Safe
Beneish M-Score -1.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 41.02
9-Day RSI 46.08
14-Day RSI 47.23
6-1 Month Momentum % -38.49
12-1 Month Momentum % -24.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.59
Quick Ratio 2.16
Cash Ratio 1.63
Days Inventory 145.34
Days Sales Outstanding 48.25
Days Payable 151.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.3

Financials (Next Earnings Date:2022-08-03 Est.)

CERS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CERS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 172.972
EPS (TTM) ($) -0.28
Beta 1.1
Volatility % 46.26
14-Day RSI 47.23
14-Day ATR ($) 0.34346
20-Day SMA ($) 4.929
12-1 Month Momentum % -24.87
52-Week Range ($) 4.38 - 8.055
Shares Outstanding (Mil) 176.9

Piotroski F-Score Details

Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cerus Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More